Cubresa is once again pleased to take part in ISMRM. Please join us at the technical exhibition at booth 505. If you would like to book at meeting in advance, please contact Lisa Bako at lbako@www.cubresa.com, or by phone at 1.204.798.4579. We look forward to seeing you in Paris!
Please join Cubresa May 6th to 8th in St. Louis, Missouri. We are pleased to take part in the 4th annual meeting and look forward to meeting the attendees. For more information, click here.
Contact us if you missed our webinar on Wednesday, July 12th where we described how Cubresa’s NuPET™ MR-compatible scanner and an existing MRI enable simultaneous preclinical hybrid imaging to better understand disease and to monitor novel treatments in small-animal models. This webinar included: Benefits of simultaneous PET/MRI Overview of the NuPET in-bore PET insert for a wide variety of MRIs…
Cubresa’s SPECT scanner was used to determine if a novel molecular label, TRV6001, in development for in vivo imaging of the BChE enzyme present in the brains of Alzheimer’s Disease patients follows the known distribution of the enzyme in animal models of the disease. Winnipeg, MB – November 22, 2016 – Cubresa Inc., a medical…
Simultaneous imaging with complementary modalities: PET & MRI If you missed our free webinar on Thursday, November 10th, you can request a link to view the recording, where you can learn how PET and MRI complement each other, and how one customer, Dr. Marty Pagel of the University of Arizona, is developing a dual-modality approach…
Cubresa’s new, larger headquarters will open for business at the following address on Tuesday September 6, 2016: Cubresa Inc. 801 Berry Street Winnipeg, MB R3H 0S7 Our telephone and facsimile numbers, as well as our e-mail addresses and web address, will remain the same. We look forward to fully utilizing our improved headquarters for research &…
Dual-modality approach being developed by the University of Arizona uses Cubresa’s NuPET™ PET scanner and a dynamic MRI technique to more fully characterize cancerous tumors. Winnipeg, MB – September 1, 2016 – Cubresa Inc., a medical imaging company that develops and markets molecular imaging systems, today announced the successful installation of their compact PET scanner called NuPET™ for…
Halifax, NS – August 5, 2016 – BIOTIC (Biomedical Translational Imaging Centre), the advanced imaging center at the IWK Health Centre, has been chosen as the first research facility to test a new preclinical PET (Positron Emission Tomography) scanner. Cubresa, a medical imaging company that develops and markets nuclear imaging systems, has developed NuPET™, a…
Cubresa to Exhibit at the WMIC 2016 Annual Congress & Exhibition in New York UPDATE: Congratulations to Patrick Chow of Bristol-Myers Squibb, on winning our custom-engraved Apple® iPad™ Pro in the booth on Saturday. Dr. Chow was selected at random from attendees who participated in our survey. Bookmark this page[1]To bookmark this page, press the Ctrl (PCs)…
Cubresa is a world leader in the design and development of clinical and preclinical PET inserts for MRI. Cubresa products enable medical professionals at leading universities, hospitals and pharmaceutical companies to visualize and measure biochemical processes at the molecular level.
About Us
Leadership
Technology
Careers
Cubresa Inc.
800-136 Market Ave
Winnipeg, MB, Canada
R3B 0P4